Plassche Douglas sold ELTP
July 8, 2025 · Form 4 insider transaction
Plassche Douglas sold 200,000 shares of Elite Pharmaceuticals, Inc. at $0.58 per share, a transaction worth $115.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
200,000
Price
$0.58
Total value
$115.8K
InsiderPlassche Douglas
Role—
SecurityStock Options (right to buy)
Transaction codeS: Open-market sale
Transaction dateJuly 8, 2025
Filing dateJuly 10, 2025
Shares owned after2,300,000
OwnershipDirect
10b5-1 planNo
AmendedNo